Arrowhead Pharma Stock Soars Pre-Market On $825M Sarepta Licensing Deal: Retail Activity Hits Year-High

Barchart · 11/26 07:46
The global licensing deal includes $500 million in cash and $325 million in equity, at a 35% premium upon closing.